[1] |
Pinninti S, Boppana S. Congenital cytomegalovirus infection diagnostics and management[J]. Curr Opin Infect Dis, 2022, 35(5): 436-441. DOI: 10.1097/QCO.0000000000000874.
|
[2] |
|
[3] |
Ssentongo P, Hehnly C, Birungi P, et al. Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening: a systematic review and Meta-analysis[J]. JAMA Netw, 2021, 4(8): e2120736. DOI: 10.1001/jamanetworkopen.2021.20736.
|
[4] |
Yamada H, Tanimura K, Fukushima S, et al. A cohort study of the universal neonatal urine screening for congenital cytomegalovirus infection[J]. J Infect Chemother, 2020, 26(8): 790-794. DOI: 10.1016/j.jiac.2020.03.009.
|
[5] |
Blázquez-Gamero D, Soriano-Ramos M, Vicente M, et al. Prevalence and clinical manifestations of congenital cytomegalovirus infection in a screening program in Madrid (PICCSA study)[J]. Pediatr Infect Dis J, 2020, 39(11): 1050-1056. DOI: 10.1097/INF.0000000000002808.
|
[6] |
Kummer P, Marcrum SC. Potential benefit of selective CMV testing after failed newborn hearing screening[J]. Int J Neonatal Screen, 2018, 4(2): 20. DOI: 10.3390/ijns4020020.
|
[7] |
Fowler KB, Ross SA, Shimamura M, et al. Racial and ethnic differences in the prevalence of congenital cytomegalovirus infection[J]. J Pediatr, 2018, 200: 196.e1-201.e1. DOI: 10.1016/j.jpeds.2018.04.043.
|
[8] |
Viswanathan R, Bafna S, Mergu R, et al. Direct saliva real-time polymerase chain reaction assay shows low birth prevalence of congenital cytomegalovirus infection in urban western India[J]. Pediatr Infect Dis J, 2019, 38(4): e65-e68. DOI: 10.1097/INF.0000000000002094.
|
[9] |
Wang C, Liu X, Wang S, et al. Late-onset hearing loss from congenital cytomegalovirus infection after newborn period in a highly immune population in China[J]. Pediatr Infect Dis J, 2021, 40(1): 70-73. DOI: 10.1097/INF.0000000000002922.
|
[10] |
Huang Y, Wang H, Li T, et al. Comparison of detection strategies for screening and confirming congenital cytomegalovirus infection in newborns in a highly seroprevalent population: a mother-child cohort study[J]. Lancet Reg Health West Pac, 2021, 12: 100182. DOI: 10.1016/j.lanwpc.2021.100182.
|
[11] |
|
[12] |
Mussi-Pinhata MM, Yamamoto AY. Natural history of congenital cytomegalovirus infection in highly seropositive populations[J]. J Infect Dis, 2020, 221(S1): S15-S22. DOI: 10.1093/infdis/jiz443.
|
[13] |
Tol I, Heath PT, Khalil A. Prevention strategies for congenital cytomegalovirus infection[J]. Curr Opin Infect Dis, 2021, 34(5): 546-551. DOI: 10.1097/QCO.0000000000000777.
|
[14] |
Shahar-Nissan K, Oikawa Tepperberg M, Mendelson E, et al. Retrospective identification of congenital cytomegalovirus infection using dried blood samples - missed opportunities and lessons[J]. J Clin Virol, 2022, 152: 105186. DOI: 10.1016/j.jcv.2022.105186.
|
[15] |
Letamendia-Richard E, Périllaud-Dubois C, de La Guillonnière L, et al. Universal newborn screening for congenital cytomegalovirus infection: feasibility and relevance in a French type-Ⅲ maternity cohort[J]. BJOG, 2022, 129(2): 291-299. DOI: 10.1111/1471-0528.16992.
|
[16] |
Ronner EA, Glovsky CK, Herrmann BS, et al. Congenital cytomegalovirus targeted screening implementation and outcomes: a retrospective chart review[J]. Otolaryngol Head Neck Surg, 2022, 167(1): 178-182. DOI: 10.1177/01945998211044125.
|
[17] |
Haller T, Shoup A, Park AH. Should hearing targeted screening for congenital cytomegalovirus infection be implemented?[J]. Int J Pediatr Otorhinolaryngol, 2020, 134: 110055. DOI: 10.1016/j.ijporl.2020.110055.
|
[18] |
Beswick R, David M, Higashi H, et al. Integration of congenital cytomegalovirus screening within a newborn hearing screening programme[J]. J Paediatr Child Health, 2019, 55(11): 1381-1388. DOI: 10.1111/jpc.14428.
|
[19] |
Fourgeaud J, Boithias C, Walter-Nicolet E, et al. Performance of targeted congenital cytomegalovirus screening in newborns failing universal hearing screening: a multicenter study[J]. Pediatr Infect Dis J, 2022, 41(6): 478-481. DOI: 10.1097/INF.0000000000003474.
|
[20] |
Nicloux M, Peterman L, Parodi M, et al. Outcome and management of newborns with congenital cytomegalovirus infection[J]. Arch Pediatr, 2020, 27(3): 160-165. DOI: 10.1016/j.arcped.2020.01.006.
|
[21] |
Mccrary H, Shi K, Newberry IC, et al. Outcomes from an expanded targeted early cytomegalovirus screening program[J]. J Pediatr Infect Dis, 2020, 15(4): 189-194. DOI: 10.1055/s-0040-1709159.
|
[22] |
Chuang Chuang Á, Ramos Hernández H, Zelada Bacigualupo Ú,et al. Congenital cytomegalovirus infection screening in high risk newborn[J]. Rev Chilena Infectol, 2021, 38(1): 45-53. DOI: 10.4067/S0716-10182021000100045.
|
[23] |
|
[24] |
Dinsmoor MJ, Fette LM, Hughes BL, et al. Amniocentesis to diagnose congenital cytomegalovirus infection following maternal primary infection[J]. Am J Obstet Gynecol MFM, 2022, 4(4): 100641. DOI: 10.1016/j.ajogmf.2022.100641.
|
[25] |
|
[26] |
|
[27] |
|
[28] |
Yamamoto AY, Anastasio ART, Massuda ET, et al. Contribution of congenital cytomegalovirus infection to permanent hearing loss in a highly seropositive population: the Brazilian cytomegalovirus hearing and maternal secondary infection study[J]. Clin Infect Dis, 2020, 70(7): 1379-1384. DOI: 10.1093/cid/ciz413.
|
[29] |
Chiereghin A, Pavia C, Turello G, et al. Universal newborn screening for congenital cytomegalovirus infection-from infant to maternal infection: a prospective multicenter study[J]. Front Pediatr, 2022, 10: 909646. DOI: 10.3389/fped.2022.909646.
|